GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Foyou Pharma Co Ltd (SHSE:601089) » Definitions » Net Income From Continuing Operations

Beijing Foyou Pharma Co (SHSE:601089) Net Income From Continuing Operations : ¥532 Mil (TTM As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Beijing Foyou Pharma Co Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Beijing Foyou Pharma Co's net income from continuing operations for the three months ended in Jun. 2024 was ¥159 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Jun. 2024 was ¥532 Mil.

Beijing Foyou Pharma Co Net Income From Continuing Operations Historical Data

The historical data trend for Beijing Foyou Pharma Co's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Foyou Pharma Co Net Income From Continuing Operations Chart

Beijing Foyou Pharma Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income From Continuing Operations
Get a 7-Day Free Trial 220.37 264.50 315.91 439.62 492.34

Beijing Foyou Pharma Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 137.10 130.75 109.31 133.53 158.91

Beijing Foyou Pharma Co Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥532 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beijing Foyou Pharma Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Foyou Pharma Co Ltd (SHSE:601089) » Definitions » Net Income From Continuing Operations
Comparable Companies
SZSE:300869 SHSE:688212 SZSE:301370 SHSE:688626 SZSE:301087 SHSE:688389 SHSE:688298 SHSE:688351 SHSE:688581 SZSE:300143 ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
N/A
Address
No. 8, Guangyuan East Street, Tongzhou Industrial Development Zone, Tongzhou District, Beijing, CHN, 101113
Website
http://www.foyou.com.cn
Beijing Winsunny Pharmaceutical Co Ltd in the research and development, production and sales of pharmaceutical preparations and medical devices.

Beijing Foyou Pharma Co Headlines

No Headlines